Targeted cancer drug trial halted after testing in 19 patients
Disease control
Terminated
This study tested an experimental drug called Promitil for people with advanced ovarian or pancreatic cancer that had specific genetic mutations and had worsened after initial treatment. The trial aimed to see if this new formulation could better control cancer growth while being…
Phase: PHASE2 • Sponsor: Lipomedix Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC